P36 Impact of inducible Nitric Oxide Synthase (iNOS) on the aggressive progression of metabolic dysfunction-associated steatotic liver disease induced by choline-deficient high-fat diet

<h3></h3> Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD) is a major global health concern and a multifaceted hepatic disorder associated with obesity, insulin resistance, and inflammatory and oxido-nitrosative stress pathways. Inducible nitric oxide synthase (iNOS), a key enzyme in nitric oxide production, has been implicated in various liver pathogenesis including MAFLD. The role of iNOS deficiency in the exacerbation of MAFLD has been a subject of debate and requires further evaluation. Hence, this study is designed to investigate the role of iNOS in the progression of MAFLD induced by a choline-deficient high-fat diet (CDHF) in mice, in comparison to wild-type (WT) and iNOS knockout (iNOS-/-) animals. Male C57BL/6 wild-type (WT) and iNOS knockout (iNOS-/-) mice were fed either a control diet or a CDHF diet for 10 and 20 weeks. Following the body weight, feeding period, metabolic function, oxidative stress, mitochondrial function, inflammatory response, and hepatic steatosis were evaluated. The mice deficient in iNOS subjected to the CDHF diet exhibited a pronounced exacerbation of MAFLD compared to WT mice. The results from the current study reveal the role of iNOS in MAFLD progression in mice fed with CDHF, by altering multiple metabolic facets including glucose metabolism, insulin sensitivity, oxidative stress, and mitochondrial dysfunction. Moreover, the decreased levels of antioxidant markers, mitochondrial biogenesis markers, and elevated levels of pro-inflammatory cytokines were observed in iNOS-/- mice, indicating a compromised defense mechanism against CDHF diet-induced liver injury in the absence of iNOS. Further, histopathological analysis revealed heightened hepatic steatosis, and inflammation, in iNOS-/- mice, indicating a possible protective role for iNOS in ameliorating CDHF diet-induced liver pathology. These findings underscore the conceivable protective function of iNOS in MAFLD, emphasizing its significance in modulating key pathological processes and paving a novel therapeutic target.

Authors

Institutions

Publication Details

Published
2024-10-01
DOI
https://doi.org/10.1136/gutjnl-2024-basl.45
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P36 Impact of inducible Nitric Oxide Synthase (iNOS) on the aggressive progression of metabolic dysfunction-associated steatotic liver disease induced by choline-deficient high-fat diet

Rajni Yadav, Parul Kamboj, Dinesh Mahajan, Ramesh K. Goyal et al.
Liver Disease Diagnosis and Treatment
article

P36 Impact of inducible Nitric Oxide Synthase (iNOS) on the aggressive progression of metabolic dysfunction-associated steatotic liver disease induced by choline-deficient high-fat diet

Rajni Yadav, Parul Kamboj, Dinesh Mahajan, Ramesh K. Goyal, S. K. Banerjee
article en

Abstract

<h3></h3> Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD) is a major global health concern and a multifaceted hepatic disorder associated with obesity, insulin resistance, and inflammatory and oxido-nitrosative stress pathways. Inducible nitric oxide synthase (iNOS), a key enzyme in nitric oxide production, has been implicated in various liver pathogenesis including MAFLD. The role of iNOS deficiency in the exacerbation of MAFLD has been a subject of debate and requires further evaluation. Hence, this study is designed to investigate the role of iNOS in the progression of MAFLD induced by a choline-deficient high-fat diet (CDHF) in mice, in comparison to wild-type (WT) and iNOS knockout (iNOS-/-) animals. Male C57BL/6 wild-type (WT) and iNOS knockout (iNOS-/-) mice were fed either a control diet or a CDHF diet for 10 and 20 weeks. Following the body weight, feeding period, metabolic function, oxidative stress, mitochondrial function, inflammatory response, and hepatic steatosis were evaluated. The mice deficient in iNOS subjected to the CDHF diet exhibited a pronounced exacerbation of MAFLD compared to WT mice. The results from the current study reveal the role of iNOS in MAFLD progression in mice fed with CDHF, by altering multiple metabolic facets including glucose metabolism, insulin sensitivity, oxidative stress, and mitochondrial dysfunction. Moreover, the decreased levels of antioxidant markers, mitochondrial biogenesis markers, and elevated levels of pro-inflammatory cytokines were observed in iNOS-/- mice, indicating a compromised defense mechanism against CDHF diet-induced liver injury in the absence of iNOS. Further, histopathological analysis revealed heightened hepatic steatosis, and inflammation, in iNOS-/- mice, indicating a possible protective role for iNOS in ameliorating CDHF diet-induced liver pathology. These findings underscore the conceivable protective function of iNOS in MAFLD, emphasizing its significance in modulating key pathological processes and paving a novel therapeutic target.

All India Institute of Medical Sciences Raipur (IN), Translational Health Science and Technology Institute (IN), Delhi Pharmaceutical Science and Research University (IN), All India Institute of Medical Sciences Bhopal (IN), National Institute of Pharmaceutical Education and Research (IN), All India Institute of Medical Sciences (IN)
Zero hunger
Openalex Percentile: Top 73%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.